A model-based approach to assess the exposure-response relationship of Lorenzo's oil in adrenoleukodystrophy.

  title={A model-based approach to assess the exposure-response relationship of Lorenzo's oil in adrenoleukodystrophy.},
  author={M. Ahmed and R. Kartha and R. Brundage and J. Cloyd and C. Basu and B. Carlin and R. Jones and A. Moser and A. Fatemi and G. Raymond},
  journal={British journal of clinical pharmacology},
  volume={81 6},
  • M. Ahmed, R. Kartha, +7 authors G. Raymond
  • Published 2016
  • Medicine
  • British journal of clinical pharmacology
  • AIMS X-linked adrenoleukodystrophy (X-ALD) is a peroxisomal disorder, most commonly affecting boys, associated with increased very long chain fatty acids (C26:0) in all tissues, causing cerebral demyelination and adrenocortical insufficiency. Certain monounsaturated long chain fatty acids including oleic and erucic acids, known as Lorenzo's oil (LO), lower plasma C26:0 levels. The aims of this study were to characterize the effect of LO administration on plasma C26:0 concentrations and to… CONTINUE READING
    3 Citations
    Focus on fatty acids in the neurometabolic pathophysiology of psychiatric disorders
    • 16
    Orphan drug development: the increasing role of clinical pharmacology
    • 5


    Dietary erucic acid therapy for X‐linked adrenoleukodystrophy
    • 182
    A two-year trial of oleic and erucic acids ("Lorenzo's oil") as treatment for adrenomyeloneuropathy.
    • 200
    Elongation of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy.
    • 76
    X-linked adrenoleukodystrophy: clinical, metabolic, genetic and pathophysiological aspects.
    • 189
    • PDF
    Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controls
    • 254
    X-linked adrenoleukodystrophy.
    • 265
    • PDF
    Effect of erucic acid on platelets in patients with adrenoleukodystrophy.
    • 17